Jahidur Rashid - Concepedia

Author

Jahidur Rashid

Texas Tech University Health Sciences Center ORCID

Also Known As

Jahidur Rashid, Rashid Jahidur

Publications

559

Citations

H-Index

Concepts

All Affiliations

Texas Tech University Health Sciences Center Texas Tech University University of Colorado Anschutz Medical Campus University of South Alabama University of Colorado Denver

About

Jahidur Rashid is an author at Texas Tech University Health Sciences Center specializing in pharmacology, medicine, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	287
2	Public Health	3	3	102
3	Engineering	2	2	65
4	Biochemistry	2	2	68
5	Allergy	1	1	67

Jahidur Rashid

Publications

376

Citations

H-Index

Page 1

	Year	Citations
Liposomal Aerosols of Nitric Oxide (NO) Donor as a Long-Acting Substitute for the Ultra-Short-Acting Inhaled NO in the Treatment of PAH Kamrun Nahar, Jahidur Rashid, Shahriar Absar, Pharmaceutical Research AsthmaLung DepositionAllergyLung InflammationNitric Oxide	2016	67
Inhaled sildenafil as an alternative to oral sildenafil in the treatment of pulmonary arterial hypertension (PAH) Jahidur Rashid, Brijeshkumar Patel, Eva Nozik‐Grayck, Journal of Controlled Release HypertensionPulmonary Arterial HypertensionPulmonary CirculationCardiovascular DiseaseMedicine	2017	54
Fasudil and SOD packaged in peptide-studded-liposomes: Properties, pharmacokinetics and ex-vivo targeting to isolated perfused rat lungs Nilesh Gupta, Fahad Alsaikhan, Brijeshkumar Patel, International Journal of Pharmaceutics Lipid PreparationNanomedicineCell-based Drug DeliveryDrug TargetingEngineering	2015	49
Fasudil and DETA NONOate, Loaded in a Peptide-Modified Liposomal Carrier, Slow PAH Progression upon Pulmonary Delivery Jahidur Rashid, Kamrun Nahar, Snehal Raut, Molecular Pharmaceutics Pah RatsPharmacotherapyLipid MovementPulmonary PharmacologyCollagen Deposition	2018	38
Cocktail of Superoxide Dismutase and Fasudil Encapsulated in Targeted Liposomes Slows PAH Progression at a Reduced Dosing Frequency Nilesh Gupta, Jahidur Rashid, Eva Nozik‐Grayck, Molecular Pharmaceutics HypertensionHeart FailureLipid PeroxidationReduced Dosing FrequencyOxidative Stress	2017	30
Repurposing rosiglitazone, a PPAR-γ agonist and oral antidiabetic, as an inhaled formulation, for the treatment of PAH Jahidur Rashid, Ahmed Alobaida, Taslim A. Al‐Hilal, Journal of Controlled Release Molecular PharmacologyPharmaceutical SciencePharmacological StudyMedicinePpar-γ Agonist	2018	29
Aerosolizable modified-release particles of montelukast improve retention and availability of the drug in the lungs Brijeshkumar Patel, Jahidur Rashid, Fakhrul Ahsan European Journal of Pharmaceutical Sciences Pharmaceutical ScienceLung DepositionAerosolizable Modified-release ParticlesPulmonary PharmacologyDrug Delivery System	2016	21
An Evaluation of Vancomycin Area Under the Curve Estimation Methods for Children Treated for Acute Pulmonary Exacerbations of Cystic Fibrosis Due to Methicillin‐Resistant <i>Staphylococcus aureus</i> Chris Stockmann, Jared Olson, Jahidur Rashid, The Journal of Clinical Pharmacology	2018	19
A highly sensitive LC–MS/MS method for concurrent determination of sildenafil and rosiglitazone in rat plasma Jahidur Rashid, Fakhrul Ahsan Journal of Pharmaceutical and Biomedical Analysis Therapeutic Drug MonitoringConcurrent DeterminationMedicineBioanalysisPhysiology	2016	18
Inhaled combination of sildenafil and rosiglitazone improves pulmonary hemodynamics, cardiac function, and arterial remodeling Jahidur Rashid, Eva Nozik‐Grayck, Ivan F. McMurtry, American Journal of Physiology-Lung Cellular and Molecular Physiology Acute Lung InjuryCardiac FunctionHypertensionHeart FailureLung Inflammation	2018	18

Page 1